Johnson & Johnson Anticipates COVID Vaccine Sales Of $2.5 Billion In 2021
July 21, 2021 at 11:24 AM EDT
Johnson & Johnson is expecting its COVID-19 vaccine to reach $2.5 billion in sales this year, despite concerns about the injection’s efficacy against the dreaded Delta variant.
